ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,507Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 1749

$1.38M Total Retail Price of All Prescriptions

Rank: 20 out of 1749

506 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 506 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

5% of this provider’s 4,005 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$120 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
BUPROPION XL 693 324 10 1 18
BENZTROPINE MESYLATE 590 115 R 2 3
RISPERIDONE 561 100 3 1
OLANZAPINE 501 288 4 6
CITALOPRAM HBR 486 244 5 10
VENLAFAXINE HCL ER 417 251 6 17
CLOZAPINE 411 0 7 11
SEROQUEL XR 393 72 8 25
DIVALPROEX SODIUM ER 358 75 9 13
CYMBALTA 323 136 10 12
QUETIAPINE FUMARATE 311 122 11 4
SERTRALINE HCL 268 102 12 7
LAMOTRIGINE 266 98 13 14
TRAZODONE HCL 239 105 14 2
TOPIRAMATE 228 43 15 29
ZOLPIDEM TARTRATE 225 111 16 9
ABILIFY 200 52 17 5
MIRTAZAPINE 198 164 18 16
OXCARBAZEPINE 190 69 19 39
LITHIUM CARBONATE 173 34 20 20
SEROQUEL 157 61 21 24
LEVOTHYROXINE SODIUM 154 13 22 37
DIVALPROEX SODIUM 131 79 23 15
SIMVASTATIN 129 19 24 52
GABAPENTIN 125 25 25 27
CLONAZEPAM 125 88 25 72
METHYLPHENIDATE HCL 120 39 27 84
DONEPEZIL HCL 117 100 28 30
ESCITALOPRAM OXALATE 113 59 29 23
FLUOXETINE HCL 108 58 30 8
PAROXETINE HCL 108 39 30 19
LATUDA 107 31 32 35
HALOPERIDOL 107 0 32 21
ZIPRASIDONE HCL 105 13 34 28
LORAZEPAM 105 92 34 67
BUSPIRONE HCL 98 23 36 26
OLANZAPINE ODT 98 0 36 40
BUPROPION HCL SR 97 44 38 22
AMITRIPTYLINE HCL 83 40 R 39 47
AMLODIPINE BESYLATE 74 11 40 82
FAMOTIDINE 74 0 40 117
ALPRAZOLAM 72 42 42 71
VALPROIC ACID 72 12 42 58
HALOPERIDOL LACTATE 71 0 44 103
BUPROPION HCL 62 48 45 61
FLUPHENAZINE HCL 60 0 46 36
FLUVOXAMINE MALEATE 56 13 47 54
CHLORPROMAZINE HCL 56 12 47 48
AMPHETAMINE SALT COMBO 55 0 S2 49 53
VENLAFAXINE HCL 51 28 50 80
HYDROXYZINE PAMOATE 50 0 R 51 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.